Evaluation of Efficacy and Safety of the Concomitant of RUTI® Immunotherapy With the Standard Treatment in TB Patients

Summary

The study is an exploratory clinical trial to evaluate the efficacy and safety of the treatment with a vaccine against tuberculosis (RUTI®) given at the same time as standard treatment in patients with tuberculosis. It is a prospective, randomized (1:1), double-blind, multicentre, placebo-controlled clinical phase IIb trial.

Timeline

Start

2021-12-01

Primary completion

2022-06-30

Completion

2022-12-31

Outcome

Outcome not reported

Stopped: “Covid-19 pandemia”

Drugs

Indications